Status:
UNKNOWN
The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease
Lead Sponsor:
Keimyung University Dongsan Medical Center
Collaborating Sponsors:
Yeungnam University College of Medicine
Conditions:
COVID-19
Perception, Self
Eligibility:
All Genders
18+ years
Brief Summary
The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which...
Detailed Description
Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patie...
Eligibility Criteria
Inclusion
- Patients with inflammatory growth disease, those who agreed to participate in this study
Exclusion
- Those who are unable to understand or answer the questionnaire
- Those who declined to participate in this study
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2021
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04387279
Start Date
April 24 2020
End Date
March 30 2021
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KeimyungUniversity
Daegu, Jung-gu, South Korea, 700-712